BioCryst Pharmaceuticals (BCRX) Fails to deliver data

Key failure to deliver metrics for BioCryst Pharmaceuticals :

• Last SEC data release: 2026-06-30
• Last 15 days FTD volume: NZ$1.33 M
• Last 3 months FTD volume: NZ$6.15 M
• Last 12 months FTD volume: NZ$8.75 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BioCryst Pharmaceuticals (BCRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BioCryst Pharmaceuticals (BCRX) - since 2013

BioCryst Pharmaceuticals (BCRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Gilead Sciences GILD	NZ$9.72 M	NZ$0.11 B	🇺🇸 USA
GSK plc GSK	NZ$77.07 M	NZ$0.19 B	🇬🇧 UK
Sarepta Therapeutics SRPT	NZ$12.05 M	NZ$24.23 M	🇺🇸 USA
Repligen RGEN	NZ$31.96 M	NZ$46.81 M	🇺🇸 USA
Novavax NVAX	NZ$16.71 M	NZ$57.53 M	🇺🇸 USA
Celldex Therapeutics CLDX	NZ$1.56 M	NZ$11.19 M	🇺🇸 USA
NanoViricides NNVC	NZ$1.16 M	NZ$4.3 M	🇺🇸 USA
Cel-Sci CVM	NZ$1.14 M	NZ$5.98 M	🇺🇸 USA
Emergent BioSolutions EBS	NZ$4.22 M	NZ$7.44 M	🇺🇸 USA